Function and Therapeutic Potential of Non-Coding RNA in Ameloblastoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ameloblastoma (AB) is a prevalent, invasive odontogenic tumor with high recurrence rates.
• Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs), are implicated in various human cancers.
• The specific roles and mechanisms of ncRNAs in AB pathogenesis are not well understood.

Purpose of the Study:

• To review the current understanding of ncRNA functions in ameloblastoma.
• To explore the potential of ncRNAs as diagnostic biomarkers for AB.
• To highlight specific ncRNAs, such as miR-29a, for diagnostic and therapeutic applications.

Main Methods:

• Literature review of studies investigating ncRNAs in cancer, with a focus on ameloblastoma.
• Analysis of the regulatory roles of ncRNAs in tumor development, progression, and potential as biomarkers.
• Identification of key ncRNAs involved in AB pathogenesis.

Main Results:

• NcRNAs play significant roles in cancer, regulating processes like alternative splicing, gene expression, and protein translation.
• Emerging evidence suggests ncRNAs are involved in AB occurrence and progression.
• Specific ncRNAs, like miR-29a, show promise as diagnostic markers and therapeutic targets for AB.

Conclusions:

• NcRNAs are critical regulators in cancer development and progression.
• Further research into the biological functions and mechanisms of ncRNAs in AB is essential.
• NcRNAs represent promising novel biomarkers and therapeutic targets for ameloblastoma management.